Search results

  1. ME/CFS Science Blog

    Should we change our name: 'ME/CFS Skeptic'?

    We've finally changed our name on social media to 'ME/CFS Science'. The main reason is that we kept getting people who were upset by our old name 'ME/CFS Skeptic', thinking that we were skeptical of ME/CFS rather than claims made about the illness. It's a bit generic but hopefully the content...
  2. ME/CFS Science Blog

    Upper Airway Resistance Syndrome (UARS): a common underlying cause for all "chronic complex illnesses"? (ME/CFS, fibro, GWI, etc.)

    I already have a list of topics I would like to analyze and write about and not enough energy to do them all, unfortunately.
  3. ME/CFS Science Blog

    Available ME/CFS datasets

    Question: has anyone made an overview of publicly available dataset on ME/CFS? For example a list with links to papers or repositories where the ME/CFS dataset is available and can be downloaded by anyone, perhaps classified by topics such as immunology, metabolomics ..., etc.?
  4. ME/CFS Science Blog

    SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

    I suspect it refers to the physical component score. The Sf-36 different subscales are grouped into a physical component score (PCS) and a mental component score (MCS). PCS is calculated from: Physical functioning Role limitations due to physical health Pain General health MCS is calculated...
  5. ME/CFS Science Blog

    Brain and muscle chemistry in ME/CFS and long COVID: a 7T magnetic resonance spectroscopy study, 2025, Godlewska et al

    Made this social media summary of the study: 1) Scientists from Oxford University used one of the most powerful brain scans (7 tesla MRI) and found different results for ME/CFS and Long Covid. 2) In the 24 ME/CFS patients, there were increased levels of lactate in the anterior cingulate...
  6. ME/CFS Science Blog

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    Do I understand their view correctly that Rituximab might work if applied long enough so that new plasma cells cannot be formed. If it is applied too briefly like in the phase III trial, the B-cells are targeted but the long-lived plasma cells might still be producing antibodies?
  7. ME/CFS Science Blog

    Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study, 2025, Chang et al.

    It also seems that they are p-hacking the database for all possible connections and then publish these in separate papers, which can be quite misleading.
  8. ME/CFS Science Blog

    Comparing DNA Methylation Landscapes in Peripheral Blood from [ME/CFS] and Long COVID Patients, 2025, Peppercorn et al

    Yes quite disappointing. This paper goes against all basic statistical principles. Hard to take the authors seriously after this.
  9. ME/CFS Science Blog

    ME/CFS Skeptic - How many scientific papers are fake?

    I meant the true scientists, the people who really want to figure things out, discover truth etc, rather than academics making a career. The people who will win future Nobel prizes. I suspect that they simply ignore most of what gets published.
  10. ME/CFS Science Blog

    Oxidative Stress is a shared characteristic of ME/CFS and Long COVID, 2024, Shankar, Bonilla, Davis et al.

    Seems like the sample size increased from 16 HC, 15 ME/CFS, and 15 LC to 25, 27 and 20 respectively.
  11. ME/CFS Science Blog

    ME/CFS Skeptic - How many scientific papers are fake?

    It still find it weird that standards are so low in (medical) science. So how do real scientists deal with this: do they simply ignore 90% of the literature and only focus on results from labs/teams they know and trust?
  12. ME/CFS Science Blog

    SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

    The effects appear to be driven by sex and contraception use which were not properly matched between ME/CFS patients and healthy controls.
  13. ME/CFS Science Blog

    SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

    If we could get hold of the data, we could do this analysis ourselves and see if the result can be explained by sex and contraception. The paper states:
  14. ME/CFS Science Blog

    SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis, 2025, Moreau, Fluge, Mella et al

    There was a massive sex difference between groups: 47% of controls were males compared to only 17% in the Canadian ME cohort. So what does frequency-matching mean in this context? Pretty much all of their measures were affected by sex, suggesting that the difference between ME and HC could be...
  15. ME/CFS Science Blog

    News from Canada

    The emails are interesting. Garner and Flottorp appear very assertive and activitst-like. They try to get themselves on the committee and are very dismissive if guideline text doesn't mention psychological treatments and recovery, often suggesting that this will cause harm. They use COFFI and...
  16. ME/CFS Science Blog

    Thesis Characterising the Electrophysiological Properties of Cells in Health and Disease [on ME/CFS], 2024, Clarke

    Don't quite understand why figure 32 (below) shows decreases in % change in zeta-potential in ME/CFS patients while on Figure 21 that Murph posted above, it seems that zeta-potential increased after 1.5 hours in the ME/CFS patients. Figure 32| Normalised ζ-potential data for PBMCs incubated...
  17. ME/CFS Science Blog

    Protocol A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat [Adults] With Severe Fibromyalgia Syndrome, 2022-4, UK

    Another questionnaire, The Revised Fibromyalgia Impact Questionnaire (FIQR, range 0-100), did show a significant difference between groups. The RLZ has a score of 62.3 (57.32 to 67.28) compared to 70.70 (64.90 to 76.50) in the control group, with lower scores being better. The p-value of the...
Back
Top Bottom